Washington: Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India`s top drugmaker agreed to pay a hefty USD 500 million to settle charges over its adulterated drugs.
Gujarat: BJP workers protest against Arvind Kejriwal
IPL fixing: SC to hear Justice Mudgal panel findings
Gujarat: FIR against Kejriwal for violation of model code
Doctors` strike: Has someone from your family died? Mulayam asks mediamen